FindTrial
Sign In

Placabo

DRUG7 trials

Sponsors

Allergopharma GmbH & Co. KG, Korea Arlico Pharm. Co., Ltd, Oman Medical Speciality Board, Liverpool John Moores University, Cedars-Sinai Medical Center

Conditions

Acute BronchitisAllergic AsthmaAnalgesia AssessmentCaffeineErectile DysfunctionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)No PillPlacebo - Control

Early Phase 1

Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males
Enrolling by invitationNCT07466732
Liverpool John Moores UniversityCaffeine, No Pill, Placebo - Control
Start: 2025-12-08End: 2026-03-25Target: 15Updated: 2026-03-13

Phase 2

To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis
CompletedNCT07061925
Korea Arlico Pharm. Co., LtdAcute Bronchitis
Start: 2025-04-23End: 2025-11-26Updated: 2025-12-24
SAMe for Prevention of Liver Cancer in MASLD-Related Cirrhosis
Not yet recruitingNCT07495995
Cedars-Sinai Medical CenterMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Start: 2026-04-15End: 2031-12-31Target: 94Updated: 2026-03-31

Phase 3

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
CompletedNCT01353755
Allergopharma GmbH & Co. KGAllergic Asthma, Rhinoconjunctivitis
Start: 2009-10-31End: 2014-09-30Updated: 2014-11-13

Phase 4

Effect of Zinc Oxide Ointment on Recurrent Aphthous Stomatitis
CompletedNCT07565181
Faculty of Dental Medicine for GirlsRecurrent Aphthous Stomatitis
Start: 2025-06-30End: 2026-03-30Updated: 2026-05-04
Efficacy of Transcutaneous Electrical Neural Stimulation and Tadalafil in Men With Erectile Dysfunction: A Randomized, Double-Blind, Bi-centric, Placebo- and Sham-Controlled Trial
CompletedNCT07574268
Menoufia UniversityErectile Dysfunction
Start: 2024-06-01End: 2026-03-01Updated: 2026-05-07

Unknown Phase

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)
Not yet recruitingNCT07166666
Oman Medical Speciality BoardAnalgesia Assessment, Sedation
Start: 2025-09-01End: 2026-10-01Target: 128Updated: 2025-09-10